Mindfulness-Based Cognitive Therapy For Depression – A New Approach to Preventing Relapse
Mindfulness-based cognitive therapy (MBCT) is a group program that has been scientifically proven to reduce depression symptoms and the likelihood of relapse. It combines elements of mindfulness meditation with those from cognitive behavioral therapy, which focuses on recognizing negative thinking and teaching how to alter it.
MBCT was developed as an alternative to antidepressant medications and is often prescribed to those with chronic depression or a history of major depressive disorder who have not responded to traditional psychotherapy. Furthermore, it helps individuals reduce symptoms of anxiety and stress which could potentially play a significant role in preventing relapse.
Group therapy typically lasts eight weeks and is led by therapists who incorporate relaxation and meditation exercises into each session to promote greater self-awareness and control.
The therapists utilize techniques from mindfulness meditation, which encourages individuals to be present with their thoughts and emotions without judgment or condemnation. Furthermore, the therapists impart basic principles of cognition which can help participants recognize and manage negative thoughts more efficiently.
Though mindfulness-based cognitive therapy is commonly used to treat depression, it may also have beneficial effects on other mental health conditions. In particular, those suffering from bipolar illness, eating disorders and psychosis may find benefit from its use; however more research needs to be done in order to fully determine its effects.
Studies have demonstrated that lithium can be as effective as maintenance antidepressant medication in preventing depression relapse, but may have a greater effect on patients with histories of abuse or severe childhood trauma. Furthermore, it’s relatively inexpensive and there’s no need to take time off work while receiving treatment.
Mindfulness-based cognitive therapy (MBCT) is a novel approach to preventing depression relapse that uses systematic training in mindfulness meditation as well as elements from mindfulness-based stress reduction and cognitive behavioral therapy. It aims to teach psychological skills that target cognitive mechanisms responsible for disease recurrence.
Multiple systematic reviews and meta-analyses have demonstrated the effectiveness of MBCT in reducing the risk of relapse among those suffering from depression. It has become widely adopted clinical practice, has been endorsed by the American Psychiatric Association, and is included in national guidelines across the UK, Netherlands, Canada, and Australia.
Research into mindfulness-based cognitive therapy has proven its effectiveness, yet further study is necessary to fully assess its long-term benefits. Studies involving a longer follow-up period are needed to confirm this approach’s impact on people suffering from recurrent depression.
There is an urgent need to increase access to mindfulness-based interventions for people suffering from depression and other psychiatric illnesses. Furthermore, we must uncover the factors that contribute to their success or failure.
To identify relevant studies, we searched the databases EMBASE, PubMed/Medline, PsycINFO, CINAHL, Ebsco Host and AJOL using the search string “mindfulness-based cognitive therapy” OR “MBCT” AND “depress*”, without language or other limitations. We then checked reference lists for further references to potentially relevant studies and reviews.
